Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
CTRI |
Last refreshed on:
|
24 November 2021 |
Main ID: |
CTRI/2017/06/008908 |
Date of registration:
|
23-06-2017 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
A study on effect of Integrated Nutrition, Health, WASH, Care and Support Interventions during the Pre-pregnancy, Pregnancy and Early Childhood on linear growth of children
|
Scientific title:
|
Improving Linear Growth of Children in Low Resource Settings through Integrated Nutrition, Health, WASH, Care and Support Interventions during the Pre- and Peri-conceptional Period, Pregnancy and Early Childhood - A Randomized Controlled Trial - Women and Infants Integrated Growth Study (WINGS) |
Date of first enrolment:
|
01-07-2017 |
Target sample size:
|
13500 |
Recruitment status: |
Closed to Recruitment of Participants |
URL:
|
http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=19339 |
Study type:
|
Interventional |
Study design:
|
Randomized Factorial Trial Method of generating randomization sequence:Stratified block randomization Method of allocation concealment:Centralized Blinding and masking:Open Label
|
Phase:
|
N/A
|
|
Countries of recruitment
|
India
| | | | | | | |
Contacts
|
Name:
|
Nita Bhandari
|
Address:
|
45, Kalu Sarai
110016
New Delhi, DELHI
India |
Telephone:
|
01146043751 |
Email:
|
chrd@sas.org.in |
Affiliation:
|
Centre for Health Research and Development, Society for Applied Studies |
|
Name:
|
Nita Bhandari
|
Address:
|
45, Kalu Sarai
110016
New Delhi, DELHI
India |
Telephone:
|
01146043751 |
Email:
|
chrd@sas.org.in |
Affiliation:
|
Centre for Health Research and Development, Society for Applied Studies |
| |
Key inclusion & exclusion criteria
|
Inclusion criteria: Married and living with their husband with no child or 1 child and wish to have more children
Consent to participate
Exclusion criteria: Moving away
Population likely to relocate
Age minimum:
Age maximum:
Gender:
|
Health Condition(s) or Problem(s) studied
|
|
Intervention(s)
|
Intervention1: PRE AND PERICONCEPTION - Health: Detect and facilitate treatment of medical conditions known to affect growth of the fetus and young children: As per hospital policy Screen and treat medical conditions known to affect fetal and infant growth, bi-annual deworming Intervention2: PRE AND PERICONCEPTION - Health: Birth spacing: Family planning counselling and provision of contraceptives Intervention3: PRE AND PERICONCEPTION - Nutrition: Adequate micronutrient intake (provide and counsel): Iron folic acid and, multiple micronutrients supplementation Intervention4: PRE AND PERICONCEPTION - Nutrition: Detect and manage under nutrition: High quality protein and energy dense snacks Screen and manage malnutrition and anemia, egg or milk to women with BMI 21 kg/m2
Intervention5: PRE AND PERICONCEPTION - WASH: Promotion of personal and menstrual hygiene: Counselling Intervention6: PRE AND PERICONCEPTION - Psychosocial support: Promotion of positive thinking and problem-solving skills: Counselling Promote positive thinking and problem-solving skills, screen and manage depressive symptoms, substance abuse and exposure to second hand smoke Intervention7: PREGNANCY - Health: Antenatal care: As per WHO recommendations Minimum 8 antenatal contacts, Screen and treat medical conditions, Tetanus Toxoid immunization, deworming Intervention8: PREGNANCY - Nutrition: Provision of a protein energy supplement: Provision of High quality protein and energy dense snacks, Iron folic acid and multiple micronutrients supplementation (Calcium and vitamin D), Weight monitoring and management for low weight gain
Intervention9: PREGNANCY - WASH: Improvement of drinking water quality. Reduce fecal transmission via hand and reduce fecal load in living environment: Provision of water fil
|
Primary Outcome(s)
|
Linear growth by 24 months of age - length for age Z-score, proportion stunted
Birth weight, length
Proportion low birth weight
Proportion preterm birth
Proportion small-for gestation ageTimepoint: Linear growth by 24 months of age - length for age Z-score, proportion stunted
Birth (within 1 week)
Birth (within 1 week)
Birth (within 1 week)
Birth (within 1 week)
|
Secondary Outcome(s)
|
INTERMEDIATE OUTCOMES: Micronutrient status, anemia status and inflammatory markersTimepoint: 24 months
|
POSTPARTUM OUTCOMES - Anemia statusTimepoint: 6 months
|
CHILDREN GROWTH AND DEVELOPMENT: Neurodevelopment scoreTimepoint: 24 months
|
DISEASE BURDEN OUTCOMES (WOMEN AND CHILDREN): Prevalence of non-communicable diseases, anemia, micronutrient deficiency, malnutrition and infectious diseasesTimepoint: Throughout the study period
|
BEHAVIOUR OUTCOMES(WOMEN AND CHILDREN): Family planning, substance abuse, WASH behavioursTimepoint: Throughout the study period
|
CHILDREN GROWTH: Body composition in a subgroupTimepoint: At 1 month
|
POSTPARTUM OUTCOMES - Severe postpartum morbidityTimepoint: Day 7 of birth
|
INTERMEDIATE OUTCOMES: Mother infant bonding in a subgroupTimepoint: 6,12 and 18 months
|
WOMEN: Pregnancy outcomesTimepoint: At end of pregnancy
|
CHILD GROWTH: Weight and length growth trajectoriesTimepoint: Between birth and 24 mo
|
CHILDREN GROWTH AND DEVELOPMENT: Caregiver reported developmental outcomesTimepoint: 12 and 24 months
|
INTERMEDIATE OUTCOMES: Breastfeeding initiation within 1 hour of birthTimepoint: Up to day 7 of birth
|
INTERMEDIATE OUTCOMES: Exclusively breastfedTimepoint: 1 and 6 months
|
WOMEN: Anaemia status; Micronutrient status; inflammatory markers; Reproductive tract infectionsTimepoint: Third trimester
|
WOMEN: BMI of woman; Anaemia status; Micronutrient status; Inflammatory markers; thyroid and diabetes status;
Depression; Reproductive tract infectionsTimepoint: At the time of reporting pregnancy
|
INTERMEDIATE OUTCOMES: Severe infection in the neonatal period; Prevalence of diarrhea, dysentery, pneumonia, fever in the previous 2 weeks; Prevalence of persistent diarrhea in the previous 4 weeks; Any chronic morbidityTimepoint: 1, 6, 12, 18 and 24 months
|
POSTPARTUM OUTCOMES: BMITimepoint: 6 and 12 months postpartum
|
WOMEN: Weight gain during second and third trimesterTimepoint: Second and third trimester
|
POSTPARTUM OUTCOMES - Inflammatory markersTimepoint: 6 months
|
CHILDREN GROWTH AND DEVELOPMENT: Body size - Mean length for age Z-score, proportion stunted, mean weight for length Z-score, mean weight for age Z-score, proportion wasted and underweight, mid-upper arm circumference
Timepoint: 6,12, 24 months
|
INTERMEDIATE OUTCOMES: Complementary feedingTimepoint: 9, 12, 18, 24 months
|
POSTPARTUM OUTCOMES - Micronutrient statusTimepoint: 6 months
|
POSTPARTUM OUTCOMES - Postpartum depressionTimepoint: 2 and 12 months
|
WOMEN: Birth outcomes, stillbirthsTimepoint: End of pregnancy
|
CHILDREN GROWTH AND DEVELOPMENT: Head circumferenceTimepoint: Day 7, 12, 24 months
|
INTERMEDIATE OUTCOMES: Continued breastfeedingTimepoint: 12, 18, 24 months
|
Source(s) of Monetary Support
|
Biotechnology Industry Research Assistance Council (BIRAC) of the Department of Biotechnology, Government of India,
1st Floor ,MTNL Building ,9 , CGO Complex, Lodhi Road, New Delhi-110003
(Next to Scope Complex, Infront of Gate no. 13, JLN Stadium)
|
Bill & Melinda Gates Foundation, Seattle, USA (supplementary funds approved in September 2018)
|
Ethics review
|
Status: Approved
Approval date: 03/06/2017
Contact:
Society for Applied Studies Ethics Review Committee
|
Status: Approved
Approval date: 10/01/2019
Contact:
Society for Applied Studies Ethics Review Committee
|
Status: Approved
Approval date: 22/07/2019
Contact:
Society for Applied Studies Ethics Review Committee
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|